High Tower Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.85 - $6.04 $110,342 - $137,416	-22,751 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$4.29 - $6.05 $97,601 - $137,643	22,751 New	22,751 $132,000
Q3 2020 Nov 13, 2020	SELL	$2.97 - $5.08 $32,794 - $56,093	-11,042 Closed	0 $0
Q1 2020 May 21, 2020	BUY	$2.61 - $5.21 $341 - $682	131 Added 1.2%	11,042 $43,000
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $1,835 - $2,850	500 Added 4.8%	10,911 $42,000
Q3 2019 Nov 12, 2019	BUY	$3.89 - $7.43 $40,498 - $77,353	10,411 New	10,411 $56,000
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $23,829 - $44,927	-12,411 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $2,260 - $3,840	1,000 Added 8.76%	12,411 $38,000
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $2,390 - $4,010	1,000 Added 9.61%	11,411 $28,000
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $26,131 - $45,808	10,411	10,411 $41,000

336

95.5M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.41B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.